Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The information below reflects USP standards, manufacturer prescribing information, published pharmaceutical literature, and self-reported community sources
It places the product directly on the skin or scalp, where the target tissue is located
Pramlintide (Symlin) is the short-acting amylin analog FDA-approved 2005 for adjunctive use with insulin in type 1 and insulin-treated type 2 diabetes
It is not intended, marketed, promoted, or sold for injection, reconstitution of any substance for injection, or for any route of administration into humans or animals
Proper handling and storage are important to maintain its efficacy
US$ 22.68
US$ 27.76
US$ 21.18
US$ 21.41
US$ 27.92
US$ 27.95
US$ 25.44
US$ 28.52
